A Randomized Controlled Trial on the Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder Treated at Asker DPS as Outpatients or Inpatients at Blakstad Hospital

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to compare the effect of nutritional counseling versus no treatment in patients with schizophenia or bipolar affective disorder. The main question it aims to answer are: • Can nutritional counseling have a preventive effect on the development of cardiovascular disease in patients with schizophenia or bipolar affective disorder? Participants will meet a nutritionist at baseline to asess nutritional status, biochemical and anthropometric measurements. Then, half of the study population will receive nutritional counseling. After six weeks, the same baseline measurements will be repeated to examine any potential differences between the two groups. After the intervention, the control group will be offered the same counseling as the intervention group received during the study.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• \> 18 years

• Diagnosed with either schizophrenia/psychosis or bipolar affective disorder

• Patients treatet in Vestre Viken healthcare company, at either Asker district psychiatric center or Blakstad hospital

Locations
Other Locations
Norway
Department of Research and Delvelopment, Mental health and Addiction, Vestre Viken Hospital Trust
RECRUITING
Drammen
Vestre Viken Health Trust
RECRUITING
Drammen
Contact Information
Primary
Dawn E Peleikis, phD
dawn.peleikis@vestreviken.no
+4799405812
Backup
Camilla N Myrdal, Master
camilla.myrdal@studmed.uio.no
+4794814040
Time Frame
Start Date: 2023-09-25
Estimated Completion Date: 2028-12-01
Participants
Target number of participants: 40
Related Therapeutic Areas
Sponsors
Collaborators: University of Oslo
Leads: Vestre Viken Hospital Trust

This content was sourced from clinicaltrials.gov